Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit



Status:Completed
Conditions:Smoking Cessation, Tobacco Consumers
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 64
Updated:4/21/2016
Start Date:January 2011
End Date:February 2014

Use our guide to learn which trials are right for you!

The investigators will randomize smokers to receive 1) Varenicline + smoking
cessation/reduction counseling or 2) Placebo pill + smoking cessation/reduction counseling.
Neither the participants nor the research therapists/evaluators will know to which condition
(active or placebo pill) the participants have been assigned i.e., a double-blind study).
The medication and weekly counseling will occur for 28 days. Participants will complete
assessment measures just before the start of treatment (baseline), at the end-of-treatment,
at 1-month, 3-month, and at 6-months to determine if there are differences in tobacco use
between treatment groups.


Inclusion Criteria:

- Must smoke at least 10 cigarettes per day for past 6-months

- Must have a working cellular or land-line phone

Exclusion Criteria:

- Must not be thinking of quitting in the next 30 days, but be interested in cutting
down- Must not regularly (more than 1x/month) use tobacco products other than
cigarettes

- Must not be currently receiving tobacco dependence treatment counseling

- Must not currently be taking varenicline, bupropion, nortriptyline, or any nicotine
preparations (gum, lozenge, patch, spray, inhaler)

- Must not have positive screen on SCID-I/NP Psychotic Screen

- Must have no contraindications to using varenicline, including pregnancy, as measured
by Medical History Form
We found this trial at
1
site
New Brunswick, New Jersey 08901
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials